“The belief of Hanmi Pharm President Sung-gi Lim to develop new drugs has been glowing”
The belief of President Sung-gi Lim of Hanmi Pharm, which has focused on R&D investment for the past 15 years, has been glowing in the global pharmaceutical market.
On the 5th, Hanmi Pharm announced a license agreement for the Quantum Project, a portfolio of long-acting diabetes new drugs which ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
